Literature DB >> 25452548

CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.

Deeqa A Mahamed1, Leon E Toussaint1, Margaret S Bynoe2.   

Abstract

As an obligate intracellular pathogen, the apicomplexan parasite Toxoplasma gondii evades immune system-mediated clearance by undergoing stage differentiation to persist indefinitely in susceptible hosts. Previously, we found that mice deficient in the ectoenzyme CD73, which generates adenosine in the extracellular matrix, were resistant to chronic toxoplasmosis after oral infection with T. gondii. Resistance in CD73 knockout mice was due to a delay in parasite differentiation in the central nervous system (CNS). To further clarify the role of CD73 and extracellular adenosine in T. gondii pathogenesis, we infected wild-type (WT) and CD73(-/-) mice with T. gondii cysts systemically by the intraperitoneal (i.p.) route. In contrast to oral infection, i.p. infected CD73(-/-) mice were highly susceptible to immune-mediated pathology, with significantly increased infiltration of neutrophils and T cells into the peritoneal cavity. Administration of the broad-spectrum adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine (NECA) protected CD73(-/-) mice against T. gondii-induced immunopathology, suggesting that the absence of CD73-generated adenosine led to the increased susceptibility in these mice. Peritoneal exudate cells from infected CD73(-/-) mice produced higher levels of the inflammatory mediators nitric oxide, tumor necrosis factor alpha (TNF-α), and interleukin-1β (IL-1β), without enhanced parasite killing or clearance. Bone marrow chimeras established that CD73 expression in both hematopoietic and nonhematopoietic compartments contributes to limiting T. gondii-induced immunopathology. In addition, mice deficient in the adenosine receptor A(2A) were more susceptible to immunopathology during intraperitoneal infection with T. gondii than WT mice. Thus, extracellular adenosine is a key immune regulator that limits collateral tissue damage due to an intracellular pathogen and promotes host survival.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25452548      PMCID: PMC4294259          DOI: 10.1128/IAI.02536-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  CD73 promotes tumor growth and metastasis.

Authors:  Bin Zhang
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

2.  Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury.

Authors:  Jonathan B Volmer; Linda F Thompson; Michael R Blackburn
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

3.  Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

Authors:  György Haskó; Balázs Csóka; Balázs Koscsó; Rachna Chandra; Pál Pacher; Linda F Thompson; Edwin A Deitch; Zoltán Spolarics; László Virág; Pál Gergely; Rolando H Rolandelli; Zoltán H Németh
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

4.  CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.

Authors:  Long Wang; Jie Fan; Linda F Thompson; Yi Zhang; Tahiro Shin; Tyler J Curiel; Bin Zhang
Journal:  J Clin Invest       Date:  2011-05-02       Impact factor: 14.808

Review 5.  Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.

Authors:  Silvia Deaglio; Simon C Robson
Journal:  Adv Pharmacol       Date:  2011

6.  CD73 protects kidney from ischemia-reperfusion injury through reduction of free radicals.

Authors:  Rongrong Jian; Yong Sun; Yingjian Wang; Jerry Yu; Lingling Zhong; Ping Zhou
Journal:  APMIS       Date:  2011-11-11       Impact factor: 3.205

Review 7.  Immune cell regulation by autocrine purinergic signalling.

Authors:  Wolfgang G Junger
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

8.  CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis.

Authors:  Jeffrey H Mills; Linda F Thompson; Cynthia Mueller; Adam T Waickman; Sirpa Jalkanen; Jussi Niemela; Laura Airas; Margaret S Bynoe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

Review 9.  The inflammasomes: mechanisms of activation and function.

Authors:  Eicke Latz
Journal:  Curr Opin Immunol       Date:  2010-01-08       Impact factor: 7.486

10.  Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury.

Authors:  Cornelia Blume; Agnieszka Felix; Nelli Shushakova; Faikah Gueler; Christine Susanne Falk; Hermann Haller; Juergen Schrader
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

View more
  12 in total

1.  Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.

Authors:  Anna Junker; Christian Renn; Clemens Dobelmann; Vigneshwaran Namasivayam; Shanu Jain; Karolina Losenkova; Heikki Irjala; Sierra Duca; Ramachandran Balasubramanian; Saibal Chakraborty; Frederik Börgel; Herbert Zimmermann; Gennady G Yegutkin; Christa E Müller; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

Review 2.  Disease tolerance and immunity in host protection against infection.

Authors:  Miguel P Soares; Luis Teixeira; Luis F Moita
Journal:  Nat Rev Immunol       Date:  2017-01-03       Impact factor: 53.106

3.  Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.

Authors:  Laetitia Petit-Jentreau; Grégory Jouvion; Patricia Charles; Laleh Majlessi; Brigitte Gicquel; Ludovic Tailleux
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

4.  Leishmania infantum Parasites Subvert the Host Inflammatory Response through the Adenosine A2A Receptor to Promote the Establishment of Infection.

Authors:  Mikhael H F Lima; Lais A Sacramento; Gustavo F S Quirino; Marcela D Ferreira; Luciana Benevides; Alynne K M Santana; Fernando Q Cunha; Roque P Almeida; João S Silva; Vanessa Carregaro
Journal:  Front Immunol       Date:  2017-07-20       Impact factor: 7.561

Review 5.  Purinergic Signaling: A Common Path in the Macrophage Response against Mycobacterium tuberculosis and Toxoplasma gondii.

Authors:  Laetitia Petit-Jentreau; Ludovic Tailleux; Janine L Coombes
Journal:  Front Cell Infect Microbiol       Date:  2017-08-07       Impact factor: 5.293

6.  Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling.

Authors:  Lei Xiong; Ji-Ung Jung; Hao-Han Guo; Jin-Xiu Pan; Xiang-Dong Sun; Lin Mei; Wen-Cheng Xiong
Journal:  J Cell Biol       Date:  2017-02-13       Impact factor: 10.539

7.  CD73 promotes colitis-associated tumorigenesis in mice.

Authors:  Xuan-Hui Liu; Xian-Rui Wu; Nan Lan; Xiao-Bin Zheng; Chi Zhou; Tuo Hu; Yu-Feng Chen; Ze-Rong Cai; Ze-Xian Chen; Ping Lan; Xiao-Jian Wu
Journal:  Oncol Lett       Date:  2020-05-22       Impact factor: 2.967

8.  CD73+ Dendritic Cells in Cascading Th17 Responses of Experimental Autoimmune Uveitis-Induced Mice.

Authors:  MinHee K Ko; Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Front Immunol       Date:  2020-12-02       Impact factor: 7.561

Review 9.  Purinergic modulation of the immune response to infections.

Authors:  Natalia Eberhardt; Gastón Bergero; Yanina L Mazzocco Mariotta; M Pilar Aoki
Journal:  Purinergic Signal       Date:  2022-01-08       Impact factor: 3.765

Review 10.  ATPe Dynamics in Protozoan Parasites. Adapt or Perish.

Authors:  Natalia Lauri; Zaher Bazzi; Cora L Alvarez; María F Leal Denis; Julieta Schachter; Vanesa Herlax; Mariano A Ostuni; Pablo J Schwarzbaum
Journal:  Genes (Basel)       Date:  2018-12-27       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.